Survival factor NFIL3 restricts FOXO-induced gene expression in cancer

Megan Keniry1, Maira M Pires, Sarah Mense

  • 1Institute for Cancer Genetics, Columbia University, New York, New York 10032, USA.

Insights

Nuclear factor interleukin 3-regulated (NFIL3) represses FOXO transcription factors, impacting cancer cell survival and death. Targeting NFIL3 may offer therapeutic benefits for cancer patients by restoring FOXO-regulated gene expression.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Epigenetics

Background:

  • FOXO transcription factors regulate diverse cellular processes, including cell death and lifespan.
  • Understanding how FOXO factors select specific target genes is crucial for deciphering their varied functions.

Purpose of the Study:

  • To identify genes that modulate FOXO transcription factor activity, specifically focusing on the regulation of TRAIL (TNF-related apoptosis-inducing ligand).
  • To investigate the role of NFIL3 in FOXO-mediated gene regulation and its implications in cancer.

Main Methods:

  • A genetic screen was employed to identify modifiers of FOXO activation of the TRAIL promoter.
  • Chromatin immunoprecipitation and reporter assays were used to assess NFIL3 binding and its effect on histone acetylation.
  • Expression analysis of NFIL3 in various cancer types and correlation with patient survival.

Main Results:

  • NFIL3, a bZIP transcriptional repressor, was identified as an inhibitor of FOXO transcription factor access to the TRAIL promoter.
  • NFIL3 recruits histone deacetylase-2 (HDAC2), leading to reduced histone acetylation and repression of FOXO target genes like FAS and GADD45.
  • NFIL3 overexpression in cancers correlates with reduced patient survival and promotes tumor cell survival by repressing TRAIL and antagonizing cell death.

Conclusions:

  • NFIL3 functions as a critical regulator of FOXO-mediated gene expression by altering chromatin accessibility.
  • NFIL3's repression of specific FOXO targets, including TRAIL, contributes to cancer cell survival and poor prognosis.
  • Targeting NFIL3 presents a potential therapeutic strategy for enhancing cancer treatment efficacy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...